Pharmacoeconomics in Africa: needs, prospect and challenges

References

• Thwaites, R,Townsend, RJ. Pharmacoeconomics in the new millennium. A pharmaceutical industry perspective. Pharmacoeconomics. 1998;13:175–80.
   PubMed Web of Science ®Google Scholar
• WHO. Equitable access to essential medicines : a framework for collective action. World Health Organization; 2004. https://apps.who.int/iris/handle/10665/68571. Accessed 20 Mar 2021.
   Google Scholar
• Akande-Sholabi, W,Adebisi, YA. The impact of COVID-19 pandemic on medicine security in Africa: Nigeria as a case study. Pan Afr Med J. 2020;35(Suppl 2):73. https://doi.org/10.11604/pamj.supp.2020.35.2.23671.
   PubMedGoogle Scholar
• Hogerzeil, HV. The concept of essential medicines: lessons for rich countries. BMJ. 2004;329:1169–72.
   PubMedGoogle Scholar
• Gavaza, P,Rascati, K,Brown, C,Lawson, K,Mann, T. The state of health economic and pharmacoeconomic evaluation research in Zimbabwe: a review. Curr Ther Res. 2008;69:268–85.
   PubMed Web of Science ®Google Scholar
• Gavaza, P,Rascati, KL,Oladapo, AO,Khoza, S. The state of health economic evaluation research in Nigeria: a systematic review. Pharmacoeconomics. 2010;28:539–53.
   PubMed Web of Science ®Google Scholar
• Mori, AT,Kaale, EA. Priority setting for the implementation of artemisinin-based combination therapy policy in Tanzania: evaluation against the accountability for reasonableness framework. Implement Sci. 2012;7:18.
   PubMed Web of Science ®Google Scholar
• Sule, NS,Nerurkar, RP,Kamath, SA. Pharmacoeconomics. J Assoc Physicians India. 2002;50:1057–62.
   PubMedGoogle Scholar
• Uwizeyimana, T,Hashim, HT,Kabakambira, JD,Mujyarugamba, JC,Dushime, J,Ntacyabukura, B,et al. Drug supply situation in Rwanda during COVID-19: issues, efforts and challenges. J Pharm Policy Pract. 2021;14:12.
   PubMedGoogle Scholar
• Adebisi, YA,Agumage, I,Sylvanus, TD,Nawaila, IJ,Ekwere, WA,Nasiru, M,et al. Burden of tuberculosis and challenges facing its eradication in West Africa. Int J Infect. 2019. https://doi.org/10.5812/iji.92250.
   Google Scholar
• Lucero-Prisno, DE3rd,Adebisi, YA,Lin, X. Current efforts and challenges facing responses to 2019-nCoV in Africa. Glob Health Res Policy. 2020;5:21. https://doi.org/10.1186/s41256-020-00148-1.
   PubMedGoogle Scholar
• Mori, A,Gavaza, P,Robberstad, B. Role of pharmacoeconomics in developing countries. Farmeconomia. 2013;14:3–5.
   Google Scholar
• Pharmacoeconomics Principles, Methods and Economic Evaluation of Drug Therapies [Internet]. dokumen.tips. https://dokumen.tips/documents/pharmacoeconomics-principles-methods-and-economic-evaluation-of-drug-therapies.html. Accessed 20 Mar 2021.
   Google Scholar
• Gavaza, P,Rascati, KL,Oladapo, AO,Khoza, S. The state of health economic research in South Africa. Pharmacoeconomics. 2012;30:925–40.
   PubMed Web of Science ®Google Scholar
• Githang’a, J,Brown, B,Chitsike, I,Schroeder, K,Chekwenda-Makore, N,Majahasi, F,Ogundoyin, O,Renner, L,Petricca, K,Denburg, AE,Horton, SE,Gupta, S. The cost-effectiveness of treating childhood cancer in 4 centers across sub-Saharan Africa. Cancer. 2021;127(5):787–93. https://doi.org/10.1002/cncr.33280.
   PubMed Web of Science ®Google Scholar
• Tembo, T,Simuyandi, M,Chiyenu, K,et al. Evaluating the costs of cholera illness and cost-effectiveness of a single dose oral vaccination campaign in Lusaka, Zambia. PLoS ONE. 2019;14(5):e0215972. https://doi.org/10.1371/journal.pone.0215972.
   PubMed Web of Science ®Google Scholar
• Babar, Z-U-D,Scahill, S. Is there a role for pharmacoeconomics in developing countries? Pharmacoeconomics. 2010;28:1069–74.
   PubMed Web of Science ®Google Scholar
• Harper, JR. Is there a role for pharmacoeconomics in developing countries? Pharmacoeconomics. 2011;29:435–6.
   PubMedGoogle Scholar
• Shafie, AA,Hassali, MA. Is there a role for pharmacoeconomics in developing countries? Pharmacoeconomics. 2011;29:83–4.
   PubMedGoogle Scholar
• Mori, AT,Robberstad, B. Pharmacoeconomics and its implication on priority-setting for essential medicines in Tanzania: a systematic review. BMC Med Inform Decis Mak. 2012;12:110.
   PubMed Web of Science ®Google Scholar
• Fadare, JO,Ogunleye, O,Obiako, R,et al. Drug and therapeutics committees in Nigeria: evaluation of scope and functionality. Expert Rev Clin Pharmacol. 2018;11(12):1255–62. https://doi.org/10.1080/17512433.2018.1549488.
   PubMed Web of Science ®Google Scholar
• Matlala, M,Gous, AG,Godman, B,et al. Structure and activities of pharmacy and therapeutics committees among public hospitals in South Africa; findings and implications. Expert Rev Clin Pharmacol. 2017;10(11):1273–80.
   PubMed Web of Science ®Google Scholar
• Jakovljevic, M,Verhaeghe, N,Souliotis, K. Editorial: challenges of pharmacoeconomics in global health arena. Front Public Health. 2018;6:368.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Accelerating progress on HIV, tuberculosis, malaria, hepatitis and neglected tropical diseases: a new agenda for 2016–2030. [Internet]. 2015. http://apps.who.int/iris/bitstream/10665/204419/1/9789241510134_eng.pdf. Accessed 20 Mar 2021.
   Google Scholar
• Mathers, C,Fat, DM,Boerma, JT, editors. The global burden of disease: 2004 update. Geneva: World Health Organization; 2008.
   Google Scholar
• Adebisi, YA,Umah, JO,Olaoye, OC,Alaran, AJ,Sina-Odunsi, AB. Assessment of health budgetary allocation and expenditure toward achieving universal health coverage in Nigeria. Int J Health Life Sci. 2020. https://doi.org/10.5812/ijhls.102552.
   Google Scholar